Metagenomi GAAP EPS of -$0.55 beats by $0.03, revenue of $8.7M beats by $0.78M
Source: SeekingAlpha
2025-11-11 16:06:34 ET
More on Metagenomi
- Seeking Alpha’s Quant Rating on Metagenomi
- Historical earnings data for Metagenomi
- Financial information for Metagenomi
Read the full article on Seeking Alpha
For further details see:
Metagenomi GAAP EPS of -$0.55 beats by $0.03, revenue of $8.7M beats by $0.78M
Metagenomi Inc.
NASDAQ: MGX
MGX Trading
-3.45% G/L:
$1.54 Last:
139,522 Volume:
$1.57 Open:
MGX Latest News
March 05, 2026 04:05:00 pm
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
February 23, 2026 04:05:00 pm
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
MGX Stock Data
$58,948,399
30,863,429
9%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
